CENTRIC HEALTH Corp (TSE:CHH) – Investment analysts at Beacon Securities cut their FY2019 earnings per share (EPS) estimates for CENTRIC HEALTH in a report issued on Tuesday, November 12th. Beacon Securities analyst D. Cooper now forecasts that the company will post earnings per share of ($0.02) for the year, down from their prior forecast of ($0.01). Beacon Securities also issued estimates for CENTRIC HEALTH’s FY2020 earnings at $0.00 EPS.
Separately, Echelon Wealth Partners cut CENTRIC HEALTH from a “buy” rating to a “hold” rating in a research note on Monday, August 12th.
Shares of TSE CHH opened at C$0.15 on Friday. CENTRIC HEALTH has a twelve month low of C$0.10 and a twelve month high of C$0.39. The stock has a 50 day moving average of C$0.14 and a two-hundred day moving average of C$0.18. The stock has a market cap of $29.84 million and a P/E ratio of -2.00.
CENTRIC HEALTH (TSE:CHH) last issued its quarterly earnings data on Wednesday, August 14th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$31.49 million during the quarter, compared to the consensus estimate of C$30.80 million.
About CENTRIC HEALTH
Centric Health Corporation provides healthcare services to patients and customers in Canada. It operates through two segments, Specialty Pharmacy, and Surgical and Medical Centres. The Specialty Pharmacy segment provides traditional pharmacy services, such as compounding and dispensing medications, as well as clinical and specialty services for long term care and retirement communities.
Featured Article: Understanding Market Liquidity
Receive News & Ratings for CENTRIC HEALTH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRIC HEALTH and related companies with MarketBeat.com's FREE daily email newsletter.